Antibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunoprecipitation [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11468-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11468-1-AP, RRID:AB_2273873
- Product name
- ADRM1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated ADRM1 antibody (Cat. #11468-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: FC, IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Adhesion-regulating molecule 1 (ADRM1) can be a potential biomarker and target for bladder cancer.
Downregulation of pro-surfactant protein B contributes to the recurrence of early-stage non-small cell lung cancer by activating PGK1-mediated Akt signaling.
ADRM1/RPN13 attenuates cartilage extracellular matrix degradation via enhancing UCH37-mediated ALK5 deubiquitination.
An Interaction Landscape of Ubiquitin Signaling.
Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2.
The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
Dendritic spinopathy in transgenic mice expressing ALS/dementia-linked mutant UBQLN2.
SUMOylation of Psmd1 controls Adrm1 interaction with the proteasome.
A possible connection between adhesion regulating molecule 1 overexpression and nuclear factor kappa B activity in hepatocarcinogenesis.
Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
Yu QX, Wang JC, Liu JF, Ye LX, Guo YQ, Zheng HH
Scientific reports 2023 Sep 8;13(1):14803
Scientific reports 2023 Sep 8;13(1):14803
Downregulation of pro-surfactant protein B contributes to the recurrence of early-stage non-small cell lung cancer by activating PGK1-mediated Akt signaling.
Luo H, Li Q, Wang RT, Zhang L, Zhang W, Deng MS, Luo YY, Ji X, Wen Y, Zhou XR, Xu B, Wang D, Hu B, Jin H, Xu CX
Experimental hematology & oncology 2023 Nov 9;12(1):94
Experimental hematology & oncology 2023 Nov 9;12(1):94
ADRM1/RPN13 attenuates cartilage extracellular matrix degradation via enhancing UCH37-mediated ALK5 deubiquitination.
Zhu M, Cao Z, Mo F, Shi S, Hu J, Xu Q, Quan K, Liang J, Li W, Hong X, Zhang B, Liu X, Dai M
International journal of biological macromolecules 2023 Aug 30;247:125670
International journal of biological macromolecules 2023 Aug 30;247:125670
An Interaction Landscape of Ubiquitin Signaling.
Zhang X, Smits AH, van Tilburg GB, Jansen PW, Makowski MM, Ovaa H, Vermeulen M
Molecular cell 2017 Mar 2;65(5):941-955.e8
Molecular cell 2017 Mar 2;65(5):941-955.e8
Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2.
Osaka M, Ito D, Suzuki N
Biochemical and biophysical research communications 2016 Apr 1;472(2):324-31
Biochemical and biophysical research communications 2016 Apr 1;472(2):324-31
The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
Sparks A, Dayal S, Das J, Robertson P, Menendez S, Saville MK
Oncogene 2014 Sep 18;33(38):4685-96
Oncogene 2014 Sep 18;33(38):4685-96
Dendritic spinopathy in transgenic mice expressing ALS/dementia-linked mutant UBQLN2.
Gorrie GH, Fecto F, Radzicki D, Weiss C, Shi Y, Dong H, Zhai H, Fu R, Liu E, Li S, Arrat H, Bigio EH, Disterhoft JF, Martina M, Mugnaini E, Siddique T, Deng HX
Proceedings of the National Academy of Sciences of the United States of America 2014 Oct 7;111(40):14524-9
Proceedings of the National Academy of Sciences of the United States of America 2014 Oct 7;111(40):14524-9
SUMOylation of Psmd1 controls Adrm1 interaction with the proteasome.
Ryu H, Gygi SP, Azuma Y, Arnaoutov A, Dasso M
Cell reports 2014 Jun 26;7(6):1842-8
Cell reports 2014 Jun 26;7(6):1842-8
A possible connection between adhesion regulating molecule 1 overexpression and nuclear factor kappa B activity in hepatocarcinogenesis.
Yang X, Miao X, Wen Y, Hu J, Dai W, Yin B
Oncology reports 2012 Jul;28(1):283-90
Oncology reports 2012 Jul;28(1):283-90
Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
Fejzo MS, Dering J, Ginther C, Anderson L, Ramos L, Walsh C, Karlan B, Slamon DJ
Genes, chromosomes & cancer 2008 Oct;47(10):873-83
Genes, chromosomes & cancer 2008 Oct;47(10):873-83
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse testis tissue were subjected to SDS PAGE followed by western blot with 11468-1-AP(ADRM1 antibody) at dilution of 1:300
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of MCF-7 cells, using ADRM1 antibody 11468-1-AP at 1:50 dilution and Rhodamine-labeled goat anti-rabbit IgG (red). Blue pseudocolor = DAPI (fluorescent DNA dye).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- IP Result of anti-ADRM1 (IP:11468-1-AP, 3ug; Detection:11468-1-AP 1:500) with mouse testis tissue lysate 8000ug.
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human colon cancer using 11468-1-AP(ADRM1 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human colon cancer using 11468-1-AP(ADRM1 antibody) at dilution of 1:100 (under 40x lens)
- Sample type
- tissue